T1	Participants 351 362	51 patients
T2	Participants 532 540	patients
T3	Participants 692 705	control group
T4	Participants 728 736	patients
T5	Participants 870 889	patients in Group I
T6	Participants 902 922	patients in Group II
T7	Participants 938 966	patient in the control group
T8	Participants 1027 1043	Group I patients
T9	Participants 1065 1082	Group II patients
T10	Participants 1118 1134	Group I patients
T11	Participants 1249 1257	Group I.
